Using a purity-independent gene regulatory network, we demonstrated the importance of ITGA3 in pancreatic cancer as a prognostic marker for molecular transformation into the basal subtype and for patients who receive either chemotherapy or immunotherapy. The gene discussed is ITGA3; the disease is familial pancreatic carcinoma.